(Q43923288)

28 November 2017

title

Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in Type 1 diabetes mellitus (English)

1 reference

brain natriuretic peptide

28 November 2017

main subject

0 references

1 reference

McKenna K

1

1 reference

28 November 2017

Smith D

2

1 reference

28 November 2017

Moore K

3

1 reference

28 November 2017

Glen A

4

1 reference

28 November 2017

Tormey W

5

1 reference

28 November 2017

Thompson CJ

6

1 reference

28 November 2017

publication date

1 December 2001

1 reference

28 November 2017

1 reference

28 November 2017

volume

18

1 reference

28 November 2017

issue

12

1 reference

28 November 2017

page(s)

973-978

1 reference

Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Atrial natriuretic factor in hypertensive and normotensive diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Atrial natriuretic peptide increases urinary albumin excretion in men with type 1 diabetes mellitus and established microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

The effects of pathophysiological increments in brain natriuretic peptide in left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Brain natriuretic peptide as a cardiac hormone in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Blood levels and renal effects of atrial natriuretic peptide in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Effects of physiological increments in human alpha-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Renal clearance and isolated kidney perfusion techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Enhanced urinary excretion of albumin and β2microglobulin in essential hypertension induced by atrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

Tubular dysfunction and microalbuminuria in insulin dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0742-3071.2001.00569.X

10.1046/J.0742-3071.2001.00569.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference